New Horizon Advisors (HK) Ltd.

New Horizon Advisors (HK) Ltd.

New Horizon Advisors (HK) Ltd.

Date Founded



Suites 1702-03, 17/F,One Exchange Square,8 Connaught Place, Central,Hong Kong

Type of Company



Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

New Horizon Advisors-HK is an active manager which invests in high growth listed (non tradable A shares) and pre-IPO Chinese companies in a range of sectors including petrochemical, energy, media, high-technology, consumer products, pharmaceutical, medical technology and automotive. They prefer to invest in companies which have built specialty positions in their industry or possess unique resources, aiming to identify investment opportunities generated from the PRC stock reform and market mechanism adjustment.The firm invests in shares of excellent listed companies and acquires existing equity interest or establishes joint ventures/partnerships with unlisted companies that demonstrate high growth potential. They seek to invest in high technology companies with an outstanding management team, competitive advantage, good corporate governance, established sales channels, high barriers to entry and unique technology.New Horizon Advisors-HK values the cooperative relationship with their investee companies, the PRC government and their overseas investment partners and seeks to add value to their investee companies by leveraging the investment experience, overseas resources network and project management skills of Tamasek Holdings and SBI Holdings.The firm generally holds an investment for two to five years.

In The News
Private Equity International
September 1, 2013
Privately Speaking: Frank Tang of FountainVest Partners
Executives & Employees

Founder & President

Executive Director


Managing Director

Fund Advisor

Board of Directors

Partner at New Horizon Advisors (HK) Ltd.

Paths to New Horizon Advisors (HK) Ltd.
Potential Connections via
Relationship Science
New Horizon Advisors (HK) Ltd.
Recent Transactions
Details Hidden, Inc., Tianjin 58 Daojia Life Services Co., Ltd. purchase GoGo Tech Ltd. from Hotung International Co. Ltd., New Horizon Advisors (HK) Ltd., Centurion Investment Management Pte Ltd., Coent Venture Partners Pte. Ltd., SPH Ventures Pte. Ltd.

Details Hidden

Axiom Asia Private Capital Pte Ltd., New Horizon Advisors (HK) Ltd., TR Advisors Ltd., Aberdeen Asset Management Plc (Infrastructure), Asia-io Advisors Ltd., Source Photonics, Inc. /Private Group purchase Source Photonics, Inc. from Francisco Partners Management LP

Details Hidden

Silver Keen Development Ltd., Ningbo Yinyi Group Co. Ltd. purchase Punch Powertrain NV from Capricorn Venture Partners NV, Limburgse Reconversie Maatschappij NV, PMV, New Horizon Advisors (HK) Ltd.

Transaction Advisors
Legal Advisor

Advised onNew Horizon Advisors (HK) Ltd. purchases Punch Powertrain NV from Gimv NV, Capricorn Venture Partners NV, Limburgse Reconversie Maatschappij NV

Legal Advisor

Advised onCDH Investments Management (Hong Kong) Ltd., New Horizon Advisors (HK) Ltd., Luye Pharma Group Ltd. /Private Group purchase Luye Pharma Group Ltd. from MBK Partners, Ltd.

Advisors & Consultants
Legal Advisor

Partner at Simpson Thacher & Bartlett LLP

Legal Advisor

Of Counsel at Gibson, Dunn & Crutcher LLP

Details Hidden

Punch Powertrain NV designs and manufactures variable transmissions and hybrid power trains. It also develops and manufactures electric drives, motors, including power electronics and transfer cases. The company was founded in 1972 and is headquartered in Sint-Truiden, Belgium.

Details Hidden

Shenyang Xingqi Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of ophthalmological drugs. Its opthalmic prescription product variations include corneal, anti-bacteria, artificial tears, anti-inflammation, mydriatics, anti-allergic, antifungal, anti-hyperemia & fatigue relief, cataract prevention, and glaucoma treatment. The company was founded on July 5, 2000 and is headquartered in Shenyang, China.

Details Hidden

Shanghai Hile Bio-Technology Co., Ltd. engages in the manufacture and sale of veterinary vaccine and inactivated vaccine. It specializes in pig, poultry, and pet vaccine products. It offers inactivated rabies vaccines, avian infectious bronchitis vaccine, swine fever vaccine, porcine transmissible gastroenteritis and porcine epidemic diarrhea bivalent inactivated vaccine, highly pathogenic blue ear pig disease vaccine, porcine reproductive and respiratory syndrome vaccine, and porcine circovirus type 2 inactivated vaccine. The company was founded on July 18, 1981 and is headquartered in Shanghai, China.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by New Horizon Advisors (HK) Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of New Horizon Advisors (HK) Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and New Horizon Advisors (HK) Ltd..